MG
ADPT icon

Michael Gelband’s Adaptive Biotechnologies ADPT Stock Holding History

Michael Gelband’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
518,146
-36,874
-7% -$565K 0.07% 266
2026
Q1 		$7.7M Buy
+555,020
New +$8.84M 0.06% 302
2025
Q1 		– Sell
-246,865
Closed -$1.48M – 1405
2024
Q4 		$1.48M Buy
+246,865
New +$1.36M 0.01% 821
2024
Q1 		– Sell
-763,885
Closed -$3.74M – 1451
2023
Q4 		$3.74M Sell
763,885
-111,190
-13% -$507K 0.02% 403
2023
Q3 		$4.77M Buy
875,075
+734,803
+524% +$4.86M 0.05% 384
2023
Q2 		$941K Buy
140,272
+112,068
+397% +$833K 0.01% 1123
2023
Q1 		$249K Sell
28,204
-62,813
-69% -$554K ﹤0.01% 1517
2022
Q4 		$695K Sell
91,017
-254,547
-74% -$1.98M 0.01% 1072
2022
Q3 		$2.46M Buy
345,564
+308,252
+826% +$2.9M 0.03% 697
2022
Q2 		$302K Sell
37,312
-169,454
-82% -$1.49M ﹤0.01% 1535
2022
Q1 		$2.87M Buy
206,766
+193,889
+1,506% +$3.05M 0.04% 607
2021
Q4 		$361K Buy
+12,877
New +$395K ﹤0.01% 1582
2021
Q1 		– Sell
-10,843
Closed -$641K – 2074
2020
Q4 		$641K Sell
10,843
-1,271
-10% -$65.5K 0.01% 1100
2020
Q3 		$589K Sell
12,114
-72,402
-86% -$3.04M 0.01% 930
2020
Q2 		$4.09M Buy
+84,516
New +$3.08M 0.11% 200
2019
Q4 		– Sell
-11,908
Closed -$368K – 1491
2019
Q3 		$368K Sell
11,908
-70,225
-86% -$2.87M 0.01% 795
2019
Q2 		$3.97M Buy
+82,133
New +$3.64M 0.16% 87

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's ADPT Position: Q2 2026 in Review

Michael Gelband reduced its Adaptive Biotechnologies (ADPT) stake by 6.6% in Q2 2026, selling an estimated $565K and leaving 518,146 shares worth $11.1M. The position accounts for 0.07% of the portfolio, ranked #266.

Michael Gelband first reported a position in ADPT in Q2 2019 and has held it in 17 quarters since. 298 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Michael Gelband held 518,146 shares of Adaptive Biotechnologies worth $11.1M as of Q2 2026.
  • Michael Gelband sold 36,874 Adaptive Biotechnologies shares in Q2 2026, an estimated $565K.
  • Adaptive Biotechnologies made up 0.07% of Michael Gelband's portfolio in Q2 2026, its #266 holding.
  • Michael Gelband first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 17 quarters since.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.